Capillary rarefaction from the kidney point of view.
Capillary rarefaction from the kidney point of view.
复制标题
DOI:
10.1093/ckj/sfx133
复制
发表时间:
2018-06
影响因子:
4.6
通讯作者:
Kanbay M
中科院分区:
文献类型:
--
作者:
Afsar B;Afsar RE;Dagel T;Kaya E;Erus S;Ortiz A;Covic A;Kanbay M
Capillary rarefaction is broadly defined as a reduction in vascular density. Capillary rarefaction in the kidneys is thought to promote hypoxia, impair hemodynamic responses and predispose to chronic kidney disease (CKD) progression and hypertension development. Various mechanisms have been suggested to play a role in the development of capillary rarefaction, including inflammation, an altered endothelial-tubular epithelial cell crosstalk, a relative deficiency in angiogenic growth factors, loss of pericytes, increased activity of Transforming growth factor -β1 and thrombospondin-1, vitamin D deficiency, a link to lymphatic neoangiogenesis and INK4a/ARF (Cylin-dependent kinase inhibitor 2a; CDKN2A). In this review, we summarize the tools available to monitor capillary rarefaction noninvasively in the clinic, the contribution of capillary rarefaction to CKD and hypertension, the known mechanisms of capillary rarefaction, and potential future strategies to attenuate capillary rarefaction and reduce its negative impact. Therapeutic strategies to be explored in more detail include optimization of antihypertensive therapy, vitamin D receptor activators, sirtuin 1 activators, Hypoxia inducible factor prolyl hydroxylase inhibitors and stem cell therapy.
登录
查看更多内容
影响因子:
20.3
作者:
Franco, Marcela;Roswall, Pernilla;Pietras, Kristian
通讯作者:
Pietras, Kristian
影响因子:
6.1
作者:
Gatti, Stefano;Bruno, Stefania;Camussi, Giovanni
通讯作者:
Camussi, Giovanni
影响因子:
--
作者:
CHEN, IIH;PREWITT, RL;DOWELL, RF
通讯作者:
DOWELL, RF
影响因子:
3.2
作者:
Debbabi, H;Uzan, L;Tibiriçà, E
通讯作者:
Tibiriçà, E
影响因子:
2.5
作者:
de Bragança AC;Volpini RA;Mehrotra P;Andrade L;Basile DP
通讯作者:
Basile DP